Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2016 2
2017 3
2018 2
2019 7
2020 4
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.
Hoetzenecker K, Assinger A, Lichtenauer M, Mildner M, Schweiger T, Starlinger P, Jakab A, Berényi E, Pavo N, Zimmermann M, Gabriel C, Plass C, Gyöngyösi M, Volf I, Ankersmit HJ. Hoetzenecker K, et al. Basic Res Cardiol. 2012 Sep;107(5):292. doi: 10.1007/s00395-012-0292-2. Epub 2012 Aug 17. Basic Res Cardiol. 2012. PMID: 22899170 Free PMC article.
A single dose of APOSEC was intravenously injected in a closed chest reperfused infarction model. ...In addition, APOSEC evidenced a significant vasodilatory capacity on coronary arteries via p-eNOS and iNOS activation. ...
A single dose of APOSEC was intravenously injected in a closed chest reperfused infarction model. ...In addition, APOSEC evide …
Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine.
Gugerell A, Sorgenfrey D, Laggner M, Raimann J, Peterbauer A, Bormann D, Suessner S, Gabriel C, Moser B, Ostler T, Mildner M, Ankersmit HJ. Gugerell A, et al. Blood Transfus. 2020 Jan;18(1):30-39. doi: 10.2450/2019.0249-18. Epub 2019 Feb 21. Blood Transfus. 2020. PMID: 30865581 Free PMC article.
Allogeneic human blood-derived biological medicinal products require special attention. APOSEC(TM), the secretome harvested from selected human blood cells, is a new biological with promising regenerative capabilities. ...It could be demonstrated that all three steps contr …
Allogeneic human blood-derived biological medicinal products require special attention. APOSEC(TM), the secretome harvested from sele …
Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.
Lichtenauer M, Mildner M, Hoetzenecker K, Zimmermann M, Podesser BK, Sipos W, Berényi E, Dworschak M, Tschachler E, Gyöngyösi M, Ankersmit HJ. Lichtenauer M, et al. Basic Res Cardiol. 2011 Nov;106(6):1283-97. doi: 10.1007/s00395-011-0224-6. Epub 2011 Sep 28. Basic Res Cardiol. 2011. PMID: 21952733 Free PMC article.
Magnetic resonance imaging (MRI) and echocardiography were used to quantitate cardiac function. Analysis of soluble factors present in APOSEC was performed by enzyme-linked immunosorbent assay (ELISA) and activation of signalling cascades in human cardiomyocytes by APOS
Magnetic resonance imaging (MRI) and echocardiography were used to quantitate cardiac function. Analysis of soluble factors present in AP
Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions.
Wagner T, Traxler D, Simader E, Beer L, Narzt MS, Gruber F, Madlener S, Laggner M, Erb M, Vorstandlechner V, Gugerell A, Radtke C, Gnecchi M, Peterbauer A, Gschwandtner M, Tschachler E, Keibl C, Slezak P, Ankersmit HJ, Mildner M. Wagner T, et al. Sci Rep. 2018 Dec 20;8(1):18016. doi: 10.1038/s41598-018-36928-6. Sci Rep. 2018. PMID: 30573762 Free PMC article.
Therefore, we sought to dissect the molecular composition of EVs present in the secretome and compared wound healing-related activities of these EVs to other subfractions of the secretome and the fully supplemented secretome (MNC(aposec)). Compared to EVs derived from non- …
Therefore, we sought to dissect the molecular composition of EVs present in the secretome and compared wound healing-related activities of t …
Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer-study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II.
Gugerell A, Gouya-Lechner G, Hofbauer H, Laggner M, Trautinger F, Almer G, Peterbauer-Scherb A, Seibold M, Hoetzenecker W, Dreschl C, Mildner M, Ankersmit HJ. Gugerell A, et al. Trials. 2021 Jan 6;22(1):10. doi: 10.1186/s13063-020-04948-1. Trials. 2021. PMID: 33407796 Free PMC article.
To this end, the cell-free secretome of peripheral blood mononuclear cells (APOSEC) blended with a hydrogel will be applied topically three times weekly for 4 weeks. ...CONCLUSION: We consider our study protocol to be suitable to test topically administered APOSEC i …
To this end, the cell-free secretome of peripheral blood mononuclear cells (APOSEC) blended with a hydrogel will be applied topically …
Quantitative Hybrid Cardiac [18F]FDG-PET-MRI Images for Assessment of Cardiac Repair by Preconditioned Cardiosphere-Derived Cells.
Winkler J, Lukovic D, Mester-Tonczar J, Zlabinger K, Gugerell A, Pavo N, Jakab A, Szankai Z, Traxler D, Müller C, Spannbauer A, Riesenhuber M, Hašimbegović E, Dawkins J, Zimmermann M, Ankersmit HJ, Marbán E, Gyöngyösi M. Winkler J, et al. Mol Ther Methods Clin Dev. 2020 Jun 15;18:354-366. doi: 10.1016/j.omtm.2020.06.008. eCollection 2020 Sep 11. Mol Ther Methods Clin Dev. 2020. PMID: 32671138 Free PMC article.
We enhanced the effect of CDCs with APOSEC preconditioning (apoCDC) and investigated the reparative effect in a translational pig model of reperfused MI. Supernatants of CDCs, assessed by proteomic analysis, revealed reduced production of extracellular matrix proteins afte …
We enhanced the effect of CDCs with APOSEC preconditioning (apoCDC) and investigated the reparative effect in a translational pig mod …
Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I).
Simader E, Traxler D, Kasiri MM, Hofbauer H, Wolzt M, Glogner C, Storka A, Mildner M, Gouya G, Geusau A, Fuchs C, Eder C, Graf A, Schaden M, Golabi B, Aretin MB, Suessner S, Gabriel C, Klepetko W, Tschachler E, Ankersmit HJ. Simader E, et al. Sci Rep. 2017 Jul 24;7(1):6216. doi: 10.1038/s41598-017-06223-x. Sci Rep. 2017. PMID: 28740204 Free PMC article. Clinical Trial.
The primary outcome was the tolerability of the topical application of APOSEC. All adverse events were recorded until 17 days after the biopsy. ...No therapy-related serious adverse events occurred in any of the participants, and both low- and high-dose treatments were wel …
The primary outcome was the tolerability of the topical application of APOSEC. All adverse events were recorded until 17 days after t …
Toxicological testing of allogeneic secretome derived from peripheral mononuclear cells (APOSEC): a novel cell-free therapeutic agent in skin disease.
Wuschko S, Gugerell A, Chabicovsky M, Hofbauer H, Laggner M, Erb M, Ostler T, Peterbauer A, Suessner S, Demyanets S, Leuschner J, Moser B, Mildner M, Ankersmit HJ. Wuschko S, et al. Sci Rep. 2019 Apr 3;9(1):5598. doi: 10.1038/s41598-019-42057-5. Sci Rep. 2019. PMID: 30944367 Free PMC article.
A secretome of stressed peripheral blood mononuclear cells (APOSEC) was successfully tested in a toxicology program, supporting clinical use of the new drug candidate. ...The non-clinical data support the safe topical use of APOSEC in skin diseases related to defici …
A secretome of stressed peripheral blood mononuclear cells (APOSEC) was successfully tested in a toxicology program, supporting clini …
Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction.
Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Petneházy Ö, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M, Ankersmit HJ. Pavo N, et al. Biomaterials. 2014 Apr;35(11):3541-50. doi: 10.1016/j.biomaterials.2013.12.071. Epub 2014 Jan 16. Biomaterials. 2014. PMID: 24439416 Free article.
This study investigated the effects of catheter-based endomyocardial delivery of secretome of 2.5 10(9) apoptotic peripheral blood mononuclear cells (APOSEC) on porcine chronic post-myocardial infarction (MI) left ventricular (LV) dysfunction and on gene expression. ...A t …
This study investigated the effects of catheter-based endomyocardial delivery of secretome of 2.5 10(9) apoptotic peripheral blood mononucle …
Therapeutic potential of lipids obtained from γ-irradiated PBMCs in dendritic cell-mediated skin inflammation.
Laggner M, Copic D, Nemec L, Vorstandlechner V, Gugerell A, Gruber F, Peterbauer A, Ankersmit HJ, Mildner M. Laggner M, et al. EBioMedicine. 2020 May;55:102774. doi: 10.1016/j.ebiom.2020.102774. Epub 2020 May 8. EBioMedicine. 2020. PMID: 32403085 Free PMC article.
FUNDING: This research project was supported by the Austrian Research Promotion Agency (Vienna, Austria; grant "APOSEC" 862068; 2015-2019) and the Vienna Business Agency (Vienna, Austria; grant "APOSEC to clinic" 2343727)....
FUNDING: This research project was supported by the Austrian Research Promotion Agency (Vienna, Austria; grant "APOSEC" 862068; 2015- …
23 results